SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-022526
Filing Date
2024-07-11
Accepted
2024-07-11 08:45:30
Documents
16
Period of Report
2024-07-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nby20240711_8k.htm   iXBRL 8-K 29992
2 EXHIBIT 99.1 ex_697249.htm EX-99.1 16582
7 logo.jpg GRAPHIC 3886
  Complete submission text file 0001437749-24-022526.txt   193934

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nby-20240711.xsd EX-101.SCH 3401
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20240711_def.xml EX-101.DEF 11804
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20240711_lab.xml EX-101.LAB 15858
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20240711_pre.xml EX-101.PRE 12019
18 EXTRACTED XBRL INSTANCE DOCUMENT nby20240711_8k_htm.xml XML 2949
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33678 | Film No.: 241111102
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)